EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects

Minh-Vu H Nguyen iD, Michelle K Haas, Shannon H Kasperbauer, Vinicius Calado Nogueira de Moura, Jared J Eddy, John D Mitchell, Reeti Khare, David E Griffith, Edward D Chan, Charles L Daley

Clinical Infectious Diseases · 15.10.2024 · 79 (4) · e27-e47

DOI: 10.1093/cid/ciae421 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.08.2024. Verfasst von Minh-Vu H Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Lowerre Mycobacterial Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing in incidence globally and challenging to manage. The 2020 multisociety treatment guideline and the 2022 consensus recommendations provide comprehensive evidence-based guides to manage pulmonary diseases caused by the most common NTM. However, with >190 different NTM species that may require different multidrug regimens for treatment, the breadth and complexity of NTM-PD remain daunting for both patients and clinicians. In this narrative review, we aim to distill this broad, complex field into principles applicable to most NTM species and highlight important nuances, specifically elaborating on the presentation, diagnosis, principles of patient-centered care, principles of pathogen-directed therapy, and prospects of NTM-PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium Infections, NontuberculousNontuberculous MycobacteriaHumansLung DiseasesAnti-Bacterial Agents

Stichwörter der Autor:innen

bronchiectasiscystic fibrosismycobacteriamycobacteriummycobacteroides

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, Colorado, USA.
  • Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
  • Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado, Aurora, Colorado, USA.
  • Advanced Diagnostics Laboratories, National Jewish Health, Denver, Colorado, USA.
  • Department of Academic Affairs, National Jewish Health, Denver, Colorado, USA.
  • Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado, USA.

ORCID-Profile: Minh-Vu H Nguyen

Förderung

  • Lowerre Mycobacterial Research Fellowship

Zitieren

APA

Nguyen, M. H., Haas, M. K., Kasperbauer, S. H., Calado Nogueira de Moura, V., Eddy, J. J., Mitchell, J. D., Khare, R., Griffith, D. E., Chan, E. D., & Daley, C. L. (2024). Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clinical Infectious Diseases, 79(4), e27-e47. https://doi.org/10.1093/cid/ciae421

Vancouver

Nguyen MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, Eddy JJ, Mitchell JD, et al. Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clinical Infectious Diseases. 2024;79(4):e27-e47. doi:10.1093/cid/ciae421

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Minh-Vu H and Haas, Michelle K and Kasperbauer, Shannon H and Calado Nogueira de Moura, Vinicius and Eddy, Jared J and Mitchell, John D and Khare, Reeti and Griffith, David E and Chan, Edward D and Daley, Charles L},
  title = {Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {4},
  pages = {e27--e47},
  doi = {10.1093/cid/ciae421}
}
Kostenlos starten →